• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    18.26 Up 0.71(4.05%) Feb 12, 4:00PM EST
    |After Hours : 18.50 Up 0.24 (1.31%) Feb 12, 7:58PM EST
    Prev Close:17.55
    Open:18.10
    Bid:17.99 x 200
    Ask:19.45 x 500
    1y Target Est:48.20
    Beta:3.10231
    Earnings Date:Feb 24 - Feb 29 (Est.)
    Day's Range:17.28 - 18.49
    52wk Range:16.64 - 51.99
    Volume:2,409,503
    Avg Vol (3m):1,743,770
    Market Cap:2.03B
    P/E (ttm):N/A
    EPS (ttm):-1.48
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACAD

    Comparison

    Symbol% ChgMkt Cap
    ACADUp 4.05%2.03B
    AZNUp 1.75%74.98B
    PFEUp 0.79%181.25B
    LLYDown 0.21%75.47B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19,249.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.58
    Quarterly EPS Est (Dec-15) :-0.40
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.56

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback